SASezin Aydemir

Sezin Aydemir

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sezin Aydemir has a total of 127 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A Disseminated Adverse Drug Reaction in a Child in Response to Beta‐Lactam Patch Testing

    by Cansu Türkay, Sezin Aydemir, Leman Tuba Karakurt, Mustafa Arga

    Patch testing is considered safe in the evaluation of selected non‐immediate drug hypersensitivity reactions in both children and adults. This report describes a 2‐year‐7‐month‐old boy whose index reaction to amoxicillin–clavulanate was a non‐severe but widespread maculopapular eruption that intensified with continued dosing. Because of its extent and progression, patch testing was performed before the planned drug provocation test. A disseminated maculopapular eruption developed after patch testing, with a strong positive (2+) reaction at 48 h. This case highlights that generalized cutaneous reactions may rarely occur after patch testing, even when the initial reaction is non‐severe.

  • When cure is not enough: Parental anxiety, depression, and caregiver burden after HSCT for inborn errors of immunity

    by Sezin Aydemir, Gizem Durcan, Ekin Nurhan, Isilay Turan, Necmiye Keser Ozturk, Betul Gemici Karaaslan, Zeynep Meric, Selami Ulas, Sevgi Bilgic Eltan, Haluk Cezmi Cokuğras, et al.

    Introduction: Hematopoietic stem cell transplantation (HSCT) is curative for many children with inborn errors of immunity (IEIs). While research has largely focused on survival, immune reconstitution, and transplant‐related complications, the long‐term psychosocial impact on families of medically stable, complication‐free survivors remains poorly understood. Methods: In this cross‐sectional case–control study, 79 children with IEIs who achieved full immune reconstitution after HSCT and were free of chronic disease‐ or transplant‐related complications were compared with 69 age‐ and sex‐matched healthy controls. Parents completed the Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), and Zarit Burden Interview (ZBI). Caregivers also completed the parent‐report Strengths and Difficulties Questionnaire (SDQ). Linear regression analysis was performed to identify factors associated with caregiver burden. Results: Mothers of transplanted children had significantly higher depression, anxiety, and caregiver burden scores than control mothers (all p ≤ .001). Fathers demonstrated higher depression scores, whereas anxiety scores did not differ significantly. Maternal depression independently predicted caregiver burden ( β = .913, 95% CI 0.512–1.314, p < .001). Children in the patient group showed higher conduct problem and hyperactivity scores, with a trend toward greater internalizing difficulties. Psychological outcomes were not associated with demographic characteristics, disease‐related factors, or time since transplantation. Discussion: Despite successful immune reconstitution and the absence of chronic complications, families continued to experience substantial psychosocial burden. Maternal depressive symptoms emerged as the strongest determinant of caregiver burden. These findings suggest that medical recovery after HSCT does not necessarily translate into psychosocial recovery and support the integration of routine family‐centered psychological assessment into long‐term follow‐up care. image

  • Clinical characteristics, recurrence patterns, and re‐transfusion outcomes of allergic transfusion reactions in children: A 10‐year cohort study

    by Muhammed Aydin, Canan Koban Dogan, Mehmet Emre Bayram, Lutfiye Koru, Dilan Demir Gumus, Ecem Kahveci, Zeynep Meric, Sezin Aydemir, Betul Gemici Karaaslan, Simge Cınar Ozel, et al.

    Background: Allergic transfusion reactions (ATRs) are among the most common adverse events associated with blood transfusion in children. However, data regarding recurrent ATRs, transfusion‐associated anaphylaxis, and their clinical outcomes remain limited. We aimed to investigate the incidence, clinical characteristics, recurrence patterns, and potential risk factors for ATRs in pediatric patients. Methods: This retrospective observational study included pediatric patients who developed ATRs at a tertiary referral center between August 2016 and August 2026. Clinical records, transfusion characteristics, laboratory findings, management strategies, and follow‐up data were reviewed. Recurrent ATRs were evaluated only among patients who underwent repeated transfusions. Comparisons between groups were performed using exact non‐parametric statistical methods. Results: Among 37,496 transfusions, 69 ATR episodes occurred in 47 patients, corresponding to an overall incidence of 0.18%. Platelet concentrates were associated with the highest ATR rate (0.51%), followed by fresh frozen plasma (0.15%) and erythrocyte suspensions (0.09%). Mucocutaneous manifestations predominated, whereas transfusion‐associated anaphylaxis occurred in 9 episodes (13%), corresponding to 24 per 100,000 transfusions. Among 37 patients who underwent repeated transfusions, recurrent ATRs occurred in 13 (35%). No significant associations were identified between recurrent ATRs and the type of blood component, history of allergic disease, elevated total IgE levels, or the severity of the index reaction. Premedication before the index ATR did not differ significantly between patients with and without recurrent ATRs. Importantly, no patient experienced recurrent anaphylaxis during follow‐up; subsequent transfusions were either well tolerated or associated only with mild cutaneous manifestations. Conclusion: ATRs in children encompass a broad clinical spectrum ranging from mild cutaneous reactions to anaphylaxis. Recurrent ATRs are common among children requiring repeated transfusions, but reliable clinical predictors of recurrence were not identified. Our findings suggest that continued transfusion therapy may be feasible with careful clinical monitoring and an individualized management approach. image

  • Insights into the microcirculation in pediatric chronic spontaneous urticaria: A nailfold videocapillaroscopy study

    by Leman Tuba Karakurt, Elif Küçük, Dilek Kacar, Gizem Uslu, Seda Çevik, Ayşe Cavidan Sonkur, Sezin Aydemir, Nurhan Kasap, Fatih Haşlak, Kübra Öztürk, et al.

    Background: Chronic spontaneous urticaria (CSU) is increasingly recognized as a systemic inflammatory disease with endothelial involvement extending beyond the skin. Nailfold videocapillaroscopy (NVC) has demonstrated systemic microvascular abnormalities in adults with CSU, but pediatric data are lacking. We investigated nailfold microvascular alterations in children with CSU and their associations with disease activity, disease control, autoreactivity, and inflammatory markers. Methods: In this cross‐sectional study, 41 children with CSU underwent standardized NVC according to EULAR recommendations. Qualitative and quantitative capillaroscopic findings were compared with age‐specific normative values. Associations with Urticaria Activity Score over 7 days (UAS7), Urticaria Control Test (UCT), antinuclear antibodies (ANA), autologous serum skin test (ASST), anti‐thyroid peroxidase (anti‐TPO) antibodies, and laboratory parameters were assessed. Results: Children with CSU exhibited reduced capillary density (7.1 ± 1.3 vs. 8.1 ± 1.7), arterial diameter (9.4 ± 2.9 vs. 11.9 ± 4.0 μm), venous diameter (9.5 ± 2.8 vs. 15.1 ± 4.6 μm), apical loop diameter (12.4 ± 3.2 vs. 16.3 ± 5.5 μm), and capillary width (36.1 ± 6.7 vs. 41.5 ± 9.0 μm) (all p < .001), whereas capillary length and intercapillary distance were preserved ( p = .948 and p = .395). Capillary density correlated positively with disease duration ( r = 0.338, p = .031) and UAS7 ( r = 0.328, p = .037), and negatively with UCT ( r = −0.428, p = .005). Capillaroscopic findings were largely independent of ANA, ASST, and anti‐TPO status, supporting a reactive, non‐destructive microvascular process. Conclusions: This study provides the first in vivo evidence of systemic microvascular involvement in pediatric CSU. The capillaroscopic profile supports recurrent endothelial activation rather than destructive microangiopathy and highlights NVC as a simple, non‐invasive tool for evaluating systemic vascular involvement in children with CSU. image

  • Open Access

    Long-Term Serum Amyloid A Profile in Clinically Stable Pediatric Liver Transplant Recipients

    by Sezin Aydemir, İlGin Özden, Zerrin Önal, Serdar Cantez, Özlem Durmaz

    Background/Aims: Serum amyloid A (SAA) is an acute-phase protein whose sustained elevation is required for AA amyloid fibril formation. Although AA amyloidosis is a rare complication of solid organ transplantation, the long term SAA profile of clinically stable pediatric liver transplant recipients remains unknown. This study aimed to characterize long-term SAA concentrations in this population. Materials and Methods: This observational study included 51 pediatric liver transplant recipients and 50 children with acute febrile infections. Cross-sectional SAA measurements were obtained in clinically stable recipients at least 6 months after transplantation. Children with acute febrile infections served as a high-inflammation reference group. In addition, 7 recipients underwent serial SAA measurements before transplantation and at 1 week, 1 month, and 6 months after transplantation. Results: Median SAA concentrations were significantly lower in clinically stable transplant recipients than in children with acute infection (4.2 mg/L [0.7-71.8] vs. 172 mg/L [1.5-961], P < .001). SAA concentrations ≥10 mg/L were observed in 14% of transplant recipients and 96% of children with acute infections. In the longitudinal subgroup, SAA concentrations increased during the early postoperative period and declined toward baseline by 6 months (P = .014). Conclusion: SAA concentrations were generally low in clinically stable pediatric liver transplant recipients during long-term follow-up but were substantially higher in children with acute infections. These findings provide insight into long-term SAA concentrations in this population and address an important gap in the literature. Cite this article as: Aydemir S, Özden İ, Önal Z, Cantez S, Durmaz Ö. Long-term serum amyloid a profile in clinically stable pediatric liver transplant recipients. Turk J Gastroenterol. Published online September 30, 2026. doi: 10.5152/tjg.2026.26525.

  • Drug Provocation Testing in Children With Suspected Macrolide Hypersensitivity: Confirmation and Subsequent Drug Tolerance

    by Sezin Aydemir, Cansu Türkay, Leman Tuba Karakurt, Özlem Cavkaytar, Mustafa Arga

    Macrolide hypersensitivity is frequently suspected in children, although hypersensitivity confirmed by drug provocation test (DPT) appears to be uncommon. This study aimed to determine the frequency of DPT-confirmed macrolide hypersensitivity in children with suspected reactions and to evaluate subsequent macrolide reuse after negative testing. In this retrospective, single-center cohort study, 82 children with suspected macrolide hypersensitivity were evaluated. Eligible patients underwent DPT according to current EAACI/ENDA recommendations; clinical characteristics, DPT results, concomitant suspected beta-lactam hypersensitivity, and subsequent macrolide use were analyzed. Fifty-six of 82 children (68.3%) underwent DPT. The initial DPT was positive in 1 child (1.8%); one additional child with an initially negative DPT reacted on re-exposure and was confirmed by repeat DPT, resulting in a final confirmation rate of 2/56 (3.6%). Most index reactions were non-immediate (59.8%), with maculopapular exanthem being the most common presentation (52.4%). Concomitant suspected beta-lactam hypersensitivity was present in 90.2% of patients. Among 32 children evaluated for both antibiotic groups, 30 (93.8%) had negative DPT results for both, and none had confirmed hypersensitivity to both a macrolide and amoxicillin-clavulanate. Among 29 children who reused a macrolide after a negative DPT, 28 (96.6%) tolerated treatment without recurrence. These findings demonstrate a substantial discrepancy between suspected and confirmed macrolide hypersensitivity in children. DPT can facilitate exclusion of macrolide hypersensitivity and safe subsequent macrolide use, potentially reducing unnecessary antibiotic restrictions.

  • A Novel GATA2 Splice-Site Mutation Associated with Familial Myelodysplastic Syndrome

    by Sezin Aydemir, Gözde Yeşil, Ayça Dilruba Aslanger, Süheyla Ocak, Funda Cipe, Salih Güler, Özgür Kaşapçopur, Esra Yücel, Ayça Kıykım

    Introduction:: GATA binding protein 2 (GATA2) deficiency is an autosomal dominant disorder characterized by immunodeficiency, progressive cytopenias, and an increased risk of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). Novel variants continue to broaden the clinical and genetic spectrum of this condition. Case Presentation:: An 11-year-old girl presented with recalcitrant cutaneous warts, recurrent infections, and multilineage cytopenias. Her father had longstanding leukopenia and MDS that progressed to AML. Laboratory evaluation revealed monocytopenia, B- and Natural killer-cell lymphopenia, and dysplastic bone marrow findings. Genetic analysis identified a previously unreported heterozygous splice-site variant in GATA2 (c.1017 + 1 G > A), confirmed in stored DNA from her deceased father. Despite supportive care and allogeneic hematopoietic stem cell transplantation from a matched unrelated donor, she developed severe graft-versus-host disease and died from transplant-related complications. Conclusion:: This report identifies a previously unreported GATA2 splice-site variant with clinical and familial evidence supporting pathogenicity, contributing to the expanding mutational spectrum and enhancing understanding of genotype–phenotype correlations in GATA2 deficiency.


  • Open Access

    Beyond immune recovery: Quality of life and psychosocial challenges in children with inborn errors of immunity after transplantation

    by Sezin Aydemir, Ekin Nurhan, Isilay Turan, Necmiye Keser Ozturk, Betul Gemici Karaaslan, Zeynep Meric, Selami Ulas, Sevgi Bilgic Eltan, Haluk Cezmi Cokuğras, Elif Karakoç Aydıner, et al.

    Introduction: Hematopoietic stem cell transplantation (HSCT) provides definitive treatment for many inborn errors of immunity (IEI). Although most children achieve full immune reconstitution, long-term psychosocial and quality-of-life outcomes in medically stable survivors remain insufficiently understood. Methods: Children aged 8–18 years with IEI who achieved complete immune recovery and had no chronic complications were included. Quality of life and psychological status were evaluated using the Pediatric Quality of Life Inventory (PedsQL-C) and the Revised Children’s Anxiety and Depression Scale (RCADS). Healthy children matched for age, sex, and sociodemographic background served as controls. Results: Thirty-six patients and 41 controls participated. Children post-HSCT had significantly lower physical, psychosocial, and total quality-of-life scores (p = 0.022, 0.015, 0.006) and higher depression scores (p = 0.027). One-quarter of school-aged patients were not attending school, and one-third of families restricted exposure to crowded environments. Conclusion: Despite immune recovery, children remain vulnerable to psychosocial challenges. These findings support incorporation of routine psychological assessment and family counseling into long-term post-HSCT follow‑up.

  • Vulnerability beyond infection: Effects of peer victimization on quality of life and psychosocial well‐being in inborn errors of immunity

    by Zeynep Meric, Gizem Durcan, Zehra Beyza Coban, Beril Kara Esen, Rumeysa Deniz Dedeli, Betul Gemici Karaaslan, Dilan Demir Gumus, Muhammed Aydin, Sezin Aydemir, Mesut Yavuz, et al.

    Background: Inborn errors of immunity (IEIs) comprise a heterogeneous group of over 500 genetic disorders characterized by increased susceptibility to infections, autoimmunity, and malignancy. Beyond their biological burden, IEIs may impose substantial psychosocial challenges due to frequent hospitalizations, prolonged treatments, and perceived social differences. Although bullying is a recognized determinant of anxiety, depression, and impaired quality of life (QoL), its impact in children with IEIs remains poorly understood. This study investigated the relationship between peer victimization (PV), psychological symptoms, and QoL among children with IEI. Methods: A case–control study was conducted at the Department of Pediatric Immunology and Allergy, ***University, including children aged 8–18 years with confirmed IEI and healthy controls (HCs) with similar age and sex distribution. Questionnaires were used to evaluate the PV, psychological status, and QOL of children and adolescents with and without IEI. Results: Fifty‐nine patients and sixty‐five HCs (median age 13 years) were enrolled. Predominantly antibody deficiencies represented the most common IEI category (39%). No significant difference was found between the study and HCs for PV, depression state and trait anxiety. Patients demonstrated significantly lower PedsQL school, psychosocial, and total scores compared with HCs ( p = .004, p = .021, p = .018, respectively). Peer victimization correlated negatively with psychosocial health and positively with anxiety and depression scores. Regression analysis identified peers' awareness of the illness, RCADS total score and property‐related victimization as independent predictors of poorer psychosocial outcomes. Conclusion: Children with IEI constitute a psychosocially vulnerable population. Routine psychosocial screening and integrated mental health support are essential for comprehensive care and improved quality of life.

  • Open Access

    Breath of relief: Transforming pediatric asthma care with telemedicine‐guided exercises

    by Betul Gemici Karaaslan, Hikmet Ucgun, Meltem Kaya, Gokce Nuran Cengiz, Sueda Ozturk, Ozge Barut, Zeynep Korkut, Sezin Aydemir, Zeynep Meric, Birol Topcu, et al.

    Background: Alternative non‐pharmacological strategies such as breathing exercises can be used in combination with pharmacological treatments.Objective: The aim of this randomized, controlled, single‐blind study was to investigate the effectiveness of breathing exercises in asthma patients on respiratory function, symptom control and quality of life.Methods: We enrolled pediatric asthma patients who were eligible and motivated for the study and randomly assigned them to either the exercise group (EG) or the control group (CG). The CG received a postural exercise program, while the EG received a breathing exercise program. At baseline and after 12 weeks, respiratory function (FEV1‐FVC‐FEV1/FVC‐PEF), symptom control (using asthma control test, asthma control questionnaire, global initiative for asthma symptom control assessment), quality of life (using pediatric asthma quality of life questionnaire), breath‐holding test (BHT) and sit‐to‐stand test (30sSTS) were assessed and compared.Results: One hundred twelve patients were randomized, and 99 (n = 51 EG, n = 48 CG) completed the 12‐week study. Baseline data were also similar in both groups. After 12 weeks, FEV1, Peak expiratory flow (by spirometry and peak flow meter) and BHT were significantly better in EG than in CG (p = 0.01 and p = 0.007 and p = 0.005, respectively). Asthma Control Test and GINA symptom control tool values were also significantly better in both groups.Discussion: Our participants were children with mild to moderate asthma. We conclude that our results show that breathing exercises can be an effective intervention for children with partially controlled asthma with FEV1,PEF, and BHTs.